Fig. 6From: A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer modelFlow cytometry analysis of memory CD8 T and CD4 T cells and total percentages of CD4 T and CD8 T cells in spleen and blood samples at 36 days after rechallenge. A Percentages of CD4 and CD8 memory T cells in spleen. B Percentages of CD4 and CD8 memory T cells in blood. C Percentages of CD4/CD45 and CD8/CD45 in spleen. D Percentages of CD4/CD45 and CD8/CD45 in blood. Data are expressed as means ± standard error of the mean (SEM). P < 0.05 was considered statistically significant. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, NS not significant. HDXRT high-dose radiotherapy; LDXRT low-dose radiotherapy; ICIs immune checkpoint inhibitorsBack to article page